Lataa...
Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
By analyzing over 2000 samples from a randomized clinical trial, we have recently associated high levels of tumor-infiltrating lymphocytes with an excellent prognosis among triple negative breast cancer patients as well with improved clinical responses to immunogenic chemotherapy among patients bear...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3782009/ https://ncbi.nlm.nih.gov/pubmed/24073365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24720 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|